Dose comparison between prescription methods according to anatomical variations in intracavitary brachytherapy for cervical cancer
- Author:
Euncheol CHOI
1
;
Jae Ho KIM
;
Ok Bae KIM
;
Sang Jun BYUN
;
Jin Hee KIM
;
Young Kee OH
Author Information
- Publication Type:Original Article
- Keywords: Brachytherapy; Anatomy; Radiation dosage; Uterine cervical neoplasms; Variation
- MeSH: Brachytherapy; Colon, Sigmoid; Humans; Methods; Prescriptions; Radiation Dosage; Radiotherapy; Rectum; Urinary Bladder; Uterine Cervical Neoplasms
- From:Radiation Oncology Journal 2018;36(3):227-234
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: We compared how doses delivered via two-dimensional (2D) intracavitary brachytherapy (ICBT) and three-dimensional (3D) ICBT varied anatomically. MATERIALS AND METHODS: A total of 50 patients who received 30 Gy of 3D ICBT after external radiotherapy (RT) were enrolled. We compared the doses of the actual 3D and 2D ICBT plans among patients grouped according to six anatomical variations: differences in a small-bowel V2Gy, small bowel circumference, the direction of bladder distension, bladder volume, sigmoid V3.5Gy, and sigmoid circumference. Seven dose parameters were measured in line with the EMBRACE recommendations. RESULTS: In terms of bladder volume, the bladder and small-bowel D2cc values were lower in the 150–250 mL bladder volume subgroup; and the rectum, sigmoid, and bladder D2mL values were all lower in the >250 mL subgroup, for 3D vs. 2D ICBT. In the sigmoid V3.5Gy >2 mL subgroup, the sigmoid and bladder D2mL values were significantly lower for 3D than 2D ICBT. The bladder D2mL value was also significantly lower for 3D ICBT, as reflected by the sigmoid circumference. In patients with a small bowel V2.0Gy >10 mL or small bowel circumference >15%, most dose parameters were significantly lower for 3D than 2D ICBT. The bladder distension direction did not significantly affect the doses. CONCLUSION: Compared to 2D ICBT, a greater bladder volume can reduce the internal 3D ICBT organ dose without affecting the target dose.
